Cysteine-Rich Angiogenic Inducer 61 Serves as a Potential Serum Biomarker for the Remission of Adult-Onset Still's Disease-Reference-Cited by-同舟云学术

Cysteine-Rich Angiogenic Inducer 61 Serves as a Potential Serum Biomarker for the Remission of Adult-Onset Still's Disease

Published:2019-11-20 Issue: Volume:6 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Su Yutong,Wang Zhihong,Ye Junna,Feng Tienan,Wang Fan,Chi Huihui,Zhou Zhuochao,Hu Qiongyi,Liu Honglei,Cheng Xiaobing,Shi Hui,Teng Jialin,Yang Chengde,Sun Yue

Publisher

Frontiers Media SA

Subject

General Medicine

Reference38 articles.

1. Mechanisms, biomarkers and targets for adult-onset Still's disease;Feist;Nat Rev Rheumatol,2018

2. A comprehensive review on adult onset Still's disease;Giacomelli;J Autoimmun,2018

3. Autoinflammatory pathogenesis and targeted therapy for adult-onset still's Disease;Li;Clin Rev Allergy Immunol,2019

4. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease;Chen;J Rheumatol,2004

5. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity;Chi;Arthritis Res Ther,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review;Seminars in Arthritis and Rheumatism;2021-12

2. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies;Seminars in Arthritis and Rheumatism;2021-08

3. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still’s Disease From Sepsis;Frontiers in Immunology;2021-03-31

4. Correlation between serum cysteine-rich protein 61 and disease activity of antineutrophil cytoplasmic antibody–associated vasculitis;Clinical Rheumatology;2021-03-23

5. Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still’s Disease;Frontiers in Immunology;2020-09-04